van Leeuwen R - Search Results

1

Risseeuw S, Ossewaarde-van Norel J, Klaver CCW, Colijn JM, Imhof SM, van Leeuwen R. Risseeuw S, et al. Among authors: van leeuwen r. Retina. 2019 Jan;39(1):e8. doi: 10.1097/IAE.0000000000002428. Retina. 2019. PMID: 30570624 No abstract available.

2

Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

Klaver CC, Assink JJ, van Leeuwen R, Wolfs RC, Vingerling JR, Stijnen T, Hofman A, de Jong PT. Klaver CC, et al. Among authors: van leeuwen r. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2237-41. Invest Ophthalmol Vis Sci. 2001. PMID: 11527936

3

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.

van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. van Leeuwen R, et al. Arch Ophthalmol. 2003 Apr;121(4):519-26. doi: 10.1001/archopht.121.4.519. Arch Ophthalmol. 2003. PMID: 12695249

4

Epidemiology of age-related maculopathy: a review.

van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. van Leeuwen R, et al. Eur J Epidemiol. 2003;18(9):845-54. doi: 10.1023/a:1025643303914. Eur J Epidemiol. 2003. PMID: 14561043 Review.

5

Cholesterol and age-related macular degeneration: is there a link?

van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, van Duijn CM, Stricker BH, de Jong PT. van Leeuwen R, et al. Among authors: van duijn cm. Am J Ophthalmol. 2004 Apr;137(4):750-2. doi: 10.1016/j.ajo.2003.09.015. Am J Ophthalmol. 2004. PMID: 15059717

6

Dietary intake of antioxidants and risk of age-related macular degeneration.

van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, de Jong PT. van Leeuwen R, et al. JAMA. 2005 Dec 28;294(24):3101-7. doi: 10.1001/jama.294.24.3101. JAMA. 2005. PMID: 16380590

7

Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study.

Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC. Ho L, et al. Among authors: van duijn cm, van leeuwen r. Arch Ophthalmol. 2011 Jun;129(6):758-66. doi: 10.1001/archophthalmol.2011.141. Arch Ophthalmol. 2011. PMID: 21670343

8

The RD5000 database: facilitating clinical, genetic, and therapeutic studies on inherited retinal diseases.

van Huet RA, Oomen CJ, Plomp AS, van Genderen MM, Klevering BJ, Schlingemann RO, Klaver CC, van den Born LI, Cremers FP; RD5000 Study Group. van Huet RA, et al. Invest Ophthalmol Vis Sci. 2014 Nov 17;55(11):7355-60. doi: 10.1167/iovs.14-15317. Invest Ophthalmol Vis Sci. 2014. PMID: 25404643 Review.

9

Development of Refractive Errors-What Can We Learn From Inherited Retinal Dystrophies?

Hendriks M, Verhoeven VJM, Buitendijk GHS, Polling JR, Meester-Smoor MA, Hofman A; RD5000 Consortium; Kamermans M, Ingeborgh van den Born L, Klaver CCW. Hendriks M, et al. Am J Ophthalmol. 2017 Oct;182:81-89. doi: 10.1016/j.ajo.2017.07.008. Epub 2017 Jul 25. Am J Ophthalmol. 2017. PMID: 28751151 Free article.

10

Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial.

Buitendijk GHS, Schauwvlieghe AME, Vingerling JR, Schlingemann RO, Klaver CCW; comparing Bevacizumab to Ranibizumab in Age-related macular degeneration (BRAMD) Trial Research Group. Buitendijk GHS, et al. Am J Ophthalmol. 2018 Mar;187:130-137. doi: 10.1016/j.ajo.2018.01.003. Epub 2018 Jan 9. Am J Ophthalmol. 2018. PMID: 29330064 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters